Journal Article

Continued Progress in the Development of Safe and Effective RSV Immunizations

  • Cohn A
  • Hall A
New England Journal of Medicine (2023) 389(24) 2289-2290
DOI: 10.1056/nejme2311862
2Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Before 2023, there were no immunizing tools to protect older adults and all infants from illness and death due to respiratory syncytial virus (RSV). In 2023, two RSV vaccines for older adults, one ...

Cite

CITATION STYLE

APA

Cohn, A. C., & Hall, A. J. (2023). Continued Progress in the Development of Safe and Effective RSV Immunizations. New England Journal of Medicine, 389(24), 2289–2290. https://doi.org/10.1056/nejme2311862

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free